BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26964619)

  • 1. Oral fluid drug analysis in the age of new psychoactive substances.
    Øiestad EL; Øiestad ÅM; Gjelstad A; Karinen R
    Bioanalysis; 2016 Apr; 8(7):691-710. PubMed ID: 26964619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of new psychoactive substances in oral fluids by means of microextraction by packed sorbent followed by ultra-high-performance liquid chromatography-tandem mass spectrometry.
    Rocchi R; Simeoni MC; Montesano C; Vannutelli G; Curini R; Sergi M; Compagnone D
    Drug Test Anal; 2018 May; 10(5):865-873. PubMed ID: 29078252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-class analysis of new psychoactive substances and metabolites in hair by pressurized liquid extraction coupled to HPLC-HRMS.
    Montesano C; Vannutelli G; Massa M; Simeoni MC; Gregori A; Ripani L; Compagnone D; Curini R; Sergi M
    Drug Test Anal; 2017 May; 9(5):798-807. PubMed ID: 27448433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Sesame Seed Oil to Preserve and Preconcentrate Cannabinoids for Paper Spray Mass Spectrometry.
    Bills B; Manicke N
    J Am Soc Mass Spectrom; 2020 Mar; 31(3):675-684. PubMed ID: 32013413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and characterization of emerging psychoactive substances by ion mobility spectrometry.
    Armenta S; Garrigues S; de la Guardia M; Brassier J; Alcalà M; Blanco M; Perez-Alfonso C; Galipienso N
    Drug Test Anal; 2015 Apr; 7(4):280-9. PubMed ID: 24935207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The targeted analysis of New Psychoactive Substances in oral fluid through chromatographic-spectrometric methods: review of recent findings.
    Di Trana A; Berardinelli D; Tini A; Zaami S
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):750-754. PubMed ID: 35179740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of new designer drugs and their legal status in Japan].
    Kikura-Hanajiri R; Uchiyama N; Kawamura M; Ogata J; Goda Y
    Yakugaku Zasshi; 2013; 133(1):31-40. PubMed ID: 23292017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death cases involving certain new psychoactive substances: A review of the literature.
    Kraemer M; Boehmer A; Madea B; Maas A
    Forensic Sci Int; 2019 May; 298():186-267. PubMed ID: 30925344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative analysis of seized synthetic cannabinoids and synthetic cathinones by gas chromatography triple quadrupole tandem mass spectrometry.
    Gwak S; Arroyo-Mora LE; Almirall JR
    Drug Test Anal; 2015 Feb; 7(2):121-30. PubMed ID: 24827678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS.
    Oiestad EL; Johansen U; Christophersen AS; Karinen R
    Bioanalysis; 2013 Sep; 5(18):2257-68. PubMed ID: 24053241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure.
    Blandino V; Wetzel J; Kim J; Haxhi P; Curtis R; Concheiro M
    Curr Pharm Biotechnol; 2017; 18(10):796-805. PubMed ID: 29173162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of cathinones and other stimulant, psychedelic, and dissociative designer drugs in real hair samples.
    Salomone A; Gazzilli G; Di Corcia D; Gerace E; Vincenti M
    Anal Bioanal Chem; 2016 Mar; 408(8):2035-42. PubMed ID: 26680593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of 104 New Psychoactive Substances (NPS) and Other Drugs of Abuse in Oral Fluid by LC-MS-MS.
    da Cunha KF; Oliveira KD; Huestis MA; Costa JL
    J Anal Toxicol; 2020 Oct; 44(7):697-707. PubMed ID: 32685960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative measurement of synthetic cathinones in oral fluid.
    Amaratunga P; Lorenz Lemberg B; Lemberg D
    J Anal Toxicol; 2013; 37(9):622-8. PubMed ID: 24123620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS.
    Rodrigues WC; Catbagan P; Rana S; Wang G; Moore C
    J Anal Toxicol; 2013 Oct; 37(8):526-33. PubMed ID: 23946452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective screening of synthetic cannabinoids, synthetic opioids and designer benzodiazepines in data files from forensic post mortem samples analysed by UHPLC-QTOF-MS from 2014 to 2018.
    Gundersen POM; Broecker S; Slørdal L; Spigset O; Josefsson M
    Forensic Sci Int; 2020 Jun; 311():110274. PubMed ID: 32302877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis.
    Mercolini L; Protti M
    J Pharm Biomed Anal; 2016 Oct; 130():202-219. PubMed ID: 27424495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable Data Independent Acquisition and Data Mining Exploring Feature-Based Molecular Networking Analysis for Untargeted Screening of Synthetic Cannabinoids in Oral Fluid.
    de Albuquerque Cavalcanti G; Moreira Borges R; Reis Alves Carneiro G; Costa Padilha M; Gualberto Pereira HM
    J Am Soc Mass Spectrom; 2021 Sep; 32(9):2417-2424. PubMed ID: 34399051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
    Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
    J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Agents of Substance Use/Misuse.
    Michienzi AE; Borek HA
    Emerg Med Clin North Am; 2022 May; 40(2):265-281. PubMed ID: 35461623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.